(Q37763270)

22 August 2017

1 reference

title

Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy (English)

1 reference

22 August 2017

1 reference

2

Mihai G Netea

1 reference

22 August 2017

5

Bart Jan Kullberg

1 reference

22 August 2017

Jos W. M. van der Meer,

series ordinal

4

object named as

Jos W M van der Meer

1 reference

22 August 2017

author name string

Frank L van de Veerdonk

series ordinal

1

1 reference

22 August 2017

Leo A Joosten

series ordinal

3

1 reference

22 August 2017

publication date

1 November 2010

1 reference

FEMS Microbiology Reviews

22 August 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

22 August 2017

volume

34

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

1063-1075

1 reference

Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Dendritic cell-based vaccination against opportunistic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Kinetics and requirements for activation of macrophages for fungicidal activity: Effect of protein synthesis inhibitors and immunosuppressants on activation and fungicidal mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Candidal and bacterial bloodstream infections in premature neonates: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Job's Syndrome. Recurrent, "cold", staphylococcal abscesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The host cytokine responses and protective immunity in oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Candida albicans triggers interleukin-8 secretion by oral epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Candida albicans-infected oral epithelial cells augment the anti-fungal activity of human neutrophils in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Clinical practice. Acute vulvovaginitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Human dectin-1 deficiency and mucocutaneous fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Interferon-gamma in the management of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

A homozygous CARD9 mutation in a family with susceptibility to fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Immune recognition of Candida albicans beta-glucan by dectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Attributable mortality of nosocomial candidemia, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Efungumab and caspofungin: pre-clinical data supporting synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, an

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Candida albicans cell wall comprises a branched beta-D-(1-->6)-glucan with beta-D-(1-->3)-side chains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Chronic mucocutaneous candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Design of efficacy trials of cytokines in combination with antifungal drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Epithelial GM-CSF induction by Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

New perspectives on the immunology of chronic mucocutaneous candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Mannose-binding lectin and vulvovaginal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The 14th C. L. Oakley Lecture. Candida albicans HSP 90: link between protective and auto immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Pathogenicity determinants of Candida albicans: potential targets for immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Interleukin-17 and type 17 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

An integrated model of the recognition of Candida albicans by the innate immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Expression and function of Toll-like receptors 2 and 4 in human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Successful treatment of chronic disseminated candidiasis with fluconazole and a granulocyte-macrophage colony-stimulating factor combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Effective acute desensitization for immediate-type hypersensitivity to human granulocyte-monocyte colony stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

21 January 2018

Vulvovaginal candidosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

In vitro activity of antifungal combinations against Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

A novel glyco-conjugate vaccine against fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Host-microbe interactions: innate pattern recognition of fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The macrophage mannose receptor induces IL-17 in response to Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2010.00232.X

10.1111/J.1574-6976.2010.00232.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference